IAIM
JAZZ icon

International Assets Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

International Assets Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6
Closed -$1.13K – 2402
2026
Q1 		$1.13K Buy
+6
New +$1.05K ﹤0.01% 2051
2024
Q4 		– Sell
-60,161
Closed -$540 – 1340
2024
Q3 		$540 Buy
+60,161
New +$6.59M ﹤0.01% 1324
2021
Q2 		– Sell
-22
Closed -$4K – 1193
2021
Q1 		$4K Hold
22
– – ﹤0.01% 1848
2020
Q4 		$4K Buy
+22
New +$3.28K ﹤0.01% 1701

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

International Assets Investment Management's JAZZ Position: Q2 2026 in Review

International Assets Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 6 shares — an estimated $1.13K sold.

International Assets Investment Management first reported a position in JAZZ in Q4 2020 and held it in 4 quarters. The position peaked at $4K in Q1 2021. 420 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • International Assets Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • International Assets Investment Management sold 6 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.13K.
  • International Assets Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • International Assets Investment Management's Jazz Pharmaceuticals position peaked at $4K in Q1 2021.
  • 420 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.